Dogan, M. Et Al. 2012. Relationship Between Antimetabolite Toxicity and Pharmacogenetics in Turkish Cancer Patients. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.4 , 1553-1556.

Dogan, M., KARABULUT, H. G., Tukun, A., DEMİRKAZIK, A., UTKAN, G., Yalcin, B., ... Dincol, D.(2012). Relationship Between Antimetabolite Toxicity and Pharmacogenetics in Turkish Cancer Patients. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.4, 1553-1556.

Dogan, Mutlu Et Al. "Relationship Between Antimetabolite Toxicity and Pharmacogenetics in Turkish Cancer Patients," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.4, 1553-1556, 2012

Dogan, Mutlu Et Al. "Relationship Between Antimetabolite Toxicity and Pharmacogenetics in Turkish Cancer Patients." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.4, pp.1553-1556, 2012

Dogan, M. Et Al. (2012) . "Relationship Between Antimetabolite Toxicity and Pharmacogenetics in Turkish Cancer Patients." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.4, pp.1553-1556.

@article{article, author={Mutlu Dogan Et Al. }, title={Relationship Between Antimetabolite Toxicity and Pharmacogenetics in Turkish Cancer Patients}, journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION}, year=2012, pages={1553-1556} }